Timothy H. Chen, MD
Board Certifications: Radiation Oncology
Languages: English, Mandarin and Taiwanese
Locations: Hackensack, NJ
Call Hackensack, NJ: (551) 996-5900
Timothy H. Chen is medical director of the Stereotactic Radiosurgery Program Department of Radiation Oncology with Capital Health. He practices out of the Regional Cancer Care Associates Hackensack location. Prior to that he was attending radiation oncologist at Saint Clare’s Hospital; and vice chairman of the Department of Radiation Oncology, Morristown Medical Center. He received his Master of Health Care management from Harvard University.
Academic Appointments and Achievements
Professional Memberships
American Brachytherapy Society, 2001 – present
American Society for Therapeutic Radiology and Oncology, 1995 – present
American College of Radiology, 1995 – present; and American College of Radiation Oncology, 1995 – present
Education
Medical Education
Doctor of Medicine, Santiago University of Technology School of Medicine
Bachelor of Science in Medical Technology, Taipei Medical College School of Medical Technology
Residency
Chief resident/two terms, New York and Presbyterian Hospital Weill Cornell Medical College, Department of Radiation Oncology
Resident, SUNY Health Science Center at Syracuse, Department of Radiation Oncology, Upstate Medical Center
Fellowship
Visiting Fellow/Pediatric Radiation Oncology, Joint Center for Radiation Therapy, Harvard Medical School, Boston Children’s Hospital/Department of Radiation oncology
Board Certification
American Board of Radiology, 1999
Locations
Patients may schedule appointments with Dr. Chen at:
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.